Foldable, REconfigurable & Jagged devices for enhanced drug Absorption/seeding
The project aims to develop Self-configurable, Proximity Enabling Devices (SPEDs) for efficient oral delivery of protein/peptide drugs by enhancing retention and interaction with the intestinal wall.
Projectdetails
Introduction
Oral delivery of protein/peptide drugs is extremely challenging, and the majority of research in the field is based on exploring new formulations, for instance, using permeation enhancers. In recent years, some research has been done on ingestible devices for internal injections.
Proposed Approach
Here, I propose an entirely new approach based on what we have named Self-configurable, Proximity Enabling Devices (SPEDs). The idea is that these devices (the simplest ones will be rolled-up foils) will unfold in the gut, embed in the mucus layer, and align to the intestinal wall.
Importance of Proximity
It is essential that the SPED has close proximity to the intestinal wall and is retained for a while in order to ensure efficient drug delivery. The proximity will additionally allow us to study and explore the influence of nanotextures (embedded in the SPED) on the interaction with the intestinal wall as well as micromotor-based delivery.
Specific Objectives
The SPEDs will be developed and characterized with the following specific objectives:
- Understanding the SPED properties needed to penetrate mucus.
- Investigating the mechanisms for enhanced retention time.
- Exploring the SPED as a carrier for self-propelling cargo.
- Unraveling the overall behavior of SPED.
- Demonstrating anti-diabetic drug formulation delivery with at least 5% systemic uptake and showing feasibility of a wider range of applications (delivering/seeding e.g., peptide and proteins/vaccines/probiotics).
Methodology
The work will include:
- Simulations of soft materials.
- Device design.
- Micro/nano fabrication.
- Development and use of techniques for mechanical characterization of device/tissue interaction.
- Bioimaging and in vitro and in vivo studies.
Novelty
The major novelty lies in the SPED concept, providing tissue alignment/contact and unidirectional drug release. Further, the SPEDs provide a unique platform for studies on micromotors as well as nanotextures interaction with the epithelium.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.556.251 |
Totale projectbegroting | € 2.556.251 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 30-9-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- DANMARKS TEKNISKE UNIVERSITETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable ScaffoldsMAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation. | ERC Starting... | € 1.495.288 | 2024 | Details |
Modification of liposomic nano-carriers: a novel strategy for improved drug-delivery and eradication of bacterial biofilmsThis project aims to develop and evaluate a novel drug delivery system to effectively treat and eradicate bacterial biofilms, addressing significant health and economic challenges. | ERC Proof of... | € 150.000 | 2022 | Details |
Wireless magnetothermal entero-modulationThis project aims to develop a biocompatible magnetic gel for remote activation of intestinal tissue to modulate calcium signaling and neuropeptide release, addressing GI disorders non-invasively. | ERC Starting... | € 1.500.000 | 2024 | Details |
Mix and Match: One-step activation for targeted drug deliveryThis project aims to develop a novel, efficient method for on-demand attachment of targeting ligands to nanocarriers, enhancing drug delivery efficacy while reducing toxicity in cancer therapies. | ERC Proof of... | € 150.000 | 2024 | Details |
Nanostructure formation during food protein digestion and influence on intestinal transportPRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes. | ERC Consolid... | € 2.355.741 | 2023 | Details |
Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds
MAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation.
Modification of liposomic nano-carriers: a novel strategy for improved drug-delivery and eradication of bacterial biofilms
This project aims to develop and evaluate a novel drug delivery system to effectively treat and eradicate bacterial biofilms, addressing significant health and economic challenges.
Wireless magnetothermal entero-modulation
This project aims to develop a biocompatible magnetic gel for remote activation of intestinal tissue to modulate calcium signaling and neuropeptide release, addressing GI disorders non-invasively.
Mix and Match: One-step activation for targeted drug delivery
This project aims to develop a novel, efficient method for on-demand attachment of targeting ligands to nanocarriers, enhancing drug delivery efficacy while reducing toxicity in cancer therapies.
Nanostructure formation during food protein digestion and influence on intestinal transport
PRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Personalised Adaptive MedicineThe PERAMEDIC project aims to develop a desktop-sized system for personalized polypill formulation using 3D printing and precise dosing to enhance treatment outcomes and patient adherence. | EIC Pathfinder | € 1.726.876 | 2024 | Details |
INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTHiNSIGHT aims to develop precision probiotics through innovative microencapsulation for targeted delivery, enhancing gut health and addressing related diseases using advanced technology and personalized treatment. | EIC Pathfinder | € 3.194.343 | 2025 | Details |
ISOS-Implantable Ecosystems of Genetically Modified Bacteria for the Personalized Treatment of Patients with Chronic DiseasesISOS aims to create a personalized bioreactor using engineered probiotics for on-demand delivery of therapeutic compounds to treat chronic diseases like age-related macular degeneration. | EIC Pathfinder | € 2.433.300 | 2023 | Details |
SKIN MICROBIAL DEVICESSKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering. | EIC Pathfinder | € 1.718.408 | 2023 | Details |
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic DrugsDevelop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery. | EIC Pathfinder | € 2.606.250 | 2022 | Details |
Personalised Adaptive Medicine
The PERAMEDIC project aims to develop a desktop-sized system for personalized polypill formulation using 3D printing and precise dosing to enhance treatment outcomes and patient adherence.
INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTH
iNSIGHT aims to develop precision probiotics through innovative microencapsulation for targeted delivery, enhancing gut health and addressing related diseases using advanced technology and personalized treatment.
ISOS-Implantable Ecosystems of Genetically Modified Bacteria for the Personalized Treatment of Patients with Chronic Diseases
ISOS aims to create a personalized bioreactor using engineered probiotics for on-demand delivery of therapeutic compounds to treat chronic diseases like age-related macular degeneration.
SKIN MICROBIAL DEVICES
SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs
Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.